- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Methemoglobinemia.
Displaying page 1 of 1.
EudraCT Number: 2017-000290-37 | Sponsor Protocol Number: PVP-2016003 | Start Date*: 2018-11-21 | |||||||||||
Sponsor Name:Provepharm SAS | |||||||||||||
Full Title: Open label clinical study to evaluate the safety and efficacy of ProvayBlueTM (methylene blue) for the treatment of acquired methemoglobinemia | |||||||||||||
Medical condition: Acquired methemoglobinemia | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002744-14 | Sponsor Protocol Number: PRILPLEXUS1%-1.5% | Start Date*: 2015-12-23 |
Sponsor Name:Universitair Ziekenhuis Brussel | ||
Full Title: Comparative study with prilocaine 1% and prilocaine 1.5% for ultrasound guided axillary brachial plexus blockade | ||
Medical condition: - Onset of sensory and motor block - Quality and duration of the block - Influence of prilocaine on methemoglobinemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000016-19 | Sponsor Protocol Number: PSCs | Start Date*: 2018-04-04 |
Sponsor Name:Universitair ziekenhuis Brussel | ||
Full Title: Randomized comparative double blind prospective study with hyperbaric prilocaine 2 % and 3 different doses of sufentanil for elective caesarean section. | ||
Medical condition: Healthy pregnant women | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002352-91 | Sponsor Protocol Number: LIDO2017 | Start Date*: 2018-07-10 |
Sponsor Name:Dra Antònia Dalmau i LLitjós del Servicio de Anestesia, Reanimación y Terapéutica del dolor del HUB -Idibell | ||
Full Title: Randomised, Double-blind Clinical Trial to Evaluate the Reduction of Pain in the Wounds Treatment Previously Applying Lidocaine Topical Solution vs Placebo in an outpatient. | ||
Medical condition: Evaluate pain reduction during wound cleaning after previous application of topic solution of lidocaine vs. placebo | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-005077-52 | Sponsor Protocol Number: 2013LIDO | Start Date*: 2015-05-07 |
Sponsor Name:Dra. Antònia Dalmau i Llitjós. Servicio de Anestesia, Reanimación y Terapéutica del Dolor del HUB-Idibell | ||
Full Title: Double-Blind Randomized Clinical trial to assess the pain reduction in wound healing with previous application of cutaneous lidocaine solution versus placebo | ||
Medical condition: Evaluate pain reduction during wound cleaning after previous application of topic solution of lidocaine vs. placebo | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000153-31 | Sponsor Protocol Number: AIR001-CS06 | Start Date*: 2013-01-22 |
Sponsor Name:Aires Pharmaceuticals, Inc | ||
Full Title: A Phase 2, Multi-Center, Open-Label study to evaluate the intermediate/long term safety and efficacy of AIR001 in subjects with WHO Group I Pulmonary Arterial Hypertension | ||
Medical condition: Pulmonary Arterial Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) CZ (Prematurely Ended) DE (Completed) PL (Prematurely Ended) IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-001969-33 | Sponsor Protocol Number: TAK-242-2001 | Start Date*: 2020-05-28 | |||||||||||
Sponsor Name:Akaza Bioscience Limited | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Proof-of-Concept, Phase 2a Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-242 in Subj... | |||||||||||||
Medical condition: Acute Alcoholic Hepatitis Causing Decompensation of Alcohol related Cirrhosis and Acute-on-Chronic Liver Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Prematurely Ended) HU (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.